.Amgen has shared (PDF) the very first phase 3 information on its $400 million dermatitis medication...
.Biogen and UCB's gamble on advancing into period 3 astride a broken research study hopes to have ac...
.Italian biotech Aptadir Therapies has released along with the promise that its own pipeline of prec...
.Surge Lifestyle Sciences has actually met its own target in a Duchenne muscular dystrophy (DMD) stu...
.After a couple of years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma layer,...
.Achilles Rehabs has torn up its own technique. The British biotech is knocking off on its own clini...
.Aligos Therapies is actually trumpeting a midstage win in metabolic-dysfunction affiliated steatohe...
.Basilea Pharmaceutica's work building new antifungals has obtained a significant improvement from t...
.Possessing actually scooped up the U.S. rights to Capricor Rehabs' late-stage Duchenne muscle dystr...
.After dismissing the decision meeting for Applied Rehabs' metabolic disorder drug govorestat, the F...